ES2536661B1 - Protein composition - Google Patents
Protein composition Download PDFInfo
- Publication number
- ES2536661B1 ES2536661B1 ES201301105A ES201301105A ES2536661B1 ES 2536661 B1 ES2536661 B1 ES 2536661B1 ES 201301105 A ES201301105 A ES 201301105A ES 201301105 A ES201301105 A ES 201301105A ES 2536661 B1 ES2536661 B1 ES 2536661B1
- Authority
- ES
- Spain
- Prior art keywords
- tryptophan
- calcium caseinate
- composition
- supplement
- cyclamate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 title abstract description 10
- 102000004169 proteins and genes Human genes 0.000 title abstract description 10
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 13
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 13
- 108010033929 calcium caseinate Proteins 0.000 claims abstract description 10
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 5
- 235000009499 Vanilla fragrans Nutrition 0.000 claims abstract description 4
- 244000263375 Vanilla tahitensis Species 0.000 claims abstract description 4
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims abstract description 4
- 229940010172 cyclamate / saccharin Drugs 0.000 claims abstract description 4
- 239000013589 supplement Substances 0.000 claims abstract description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 3
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 3
- 239000011648 beta-carotene Substances 0.000 claims abstract description 3
- 229960002747 betacarotene Drugs 0.000 claims abstract description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 3
- 239000000047 product Substances 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 3
- 206010012374 Depressed mood Diseases 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 208000016253 exhaustion Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Composición proteínica, constituida por una mezcla en polvo aplicable como suplemento o complemento dietético, conformada a base de caseinato de calcio, y que, además, comprende triptófano. La proporción de caseinato cálcico es un 97,664% y la de triptófano es de entre un 1 y un 0,5%. Preferentemente, contiene lo siguiente: Caseinato cálcico 97,664%; Triptófano 0,6%; Aroma vainilla 0,833%; Ciclamato/sacarina 0,833%; y Colorante beta caroteno 0,07%.Protein composition, consisting of a powder mixture applicable as a dietary supplement or supplement, made up of calcium caseinate, and which also includes tryptophan. The proportion of calcium caseinate is 97.664% and that of tryptophan is between 1 and 0.5%. Preferably, it contains the following: Calcium caseinate 97.664%; Tryptophan 0.6%; Aroma vanilla 0.833%; 0.833% cyclamate / saccharin; and beta carotene dye 0.07%.
Description
55
1010
15fifteen
20twenty
2525
3030
3535
4040
45Four. Five
50fifty
DESCRIPCIONDESCRIPTION
Composition protelnica.Protelnic composition.
Objeto de la inventionObject of the invention
La invention, tal como expresa el enunciado de la presente memoria descriptiva, se refiere a una composition protelnica.The invention, as expressed in the statement of the present specification, refers to a protelnic composition.
Mas en particular, el objeto de la invention se centra en una composition protelnica en polvo a base de aminoacidos, aplicable como suplemento dietetico, especialmente destinado a personas que siguen dietas especiales como, dietas vegetarianas, para deportistas de culturismo u otras disciplinas que combinan la alimentation con el entrenamiento o dietas como la "isodieta", consistente en un sistema nutricional basado en la reduction de hidratos de carbono favoreciendo el consumo de protelnas, estando la composition preconizada constituida esencialmente a base de caseinato de calcio reforzado con triptofano.More particularly, the object of the invention is focused on a proto-organic powder composition based on amino acids, applicable as a dietary supplement, especially intended for people who follow special diets such as vegetarian diets, for bodybuilding athletes or other disciplines that combine the alimentation with training or diets such as the "isodiet", consisting of a nutritional system based on the reduction of carbohydrates favoring the consumption of proteins, with the recommended composition consisting essentially of calcium caseinate reinforced with tryptophan.
Campo de aplicacion de la inventionField of application of the invention
El campo de aplicacion de la presente invention se centra en el sector de la industria dedicado a la fabrication de composiciones nutricionales aplicables como complemento y/o suplementos dieteticos, abarcando esencialmente los constituidos a base de protelnas.The field of application of the present invention focuses on the industry sector dedicated to the manufacture of applicable nutritional compositions as a supplement and / or dietary supplements, essentially covering those made up of proteins.
Antecedentes de la inventionBackground of the invention
Como referencia al estado actual de la tecnica, hay que mencionar que, si bien existen en el mercado diferentes formulaciones y composiciones protelnicas del tipo que aqul concierne, al menos por parte del solicitante se desconoce la existencia de ninguna que presente unas caracterlsticas constitutivas y formulation semejante a la que presenta la que aqul se preconiza, segun se reivindica.As a reference to the current state of the art, it should be mentioned that, although there are different protelnic formulations and compositions on the market of the type that concerns, at least on the part of the applicant the existence of none that presents constitutive characteristics and formulation similar to the one presented here, as claimed.
Explication de la inventionExplanation of the invention
De forma concreta, lo que la invention propone es una composition protelnica a base de aminoacidos, aplicable como suplemento o complemento dietetico, especialmente para vegetarianos, deportistas o personas con estados carenciales transitorios, depresivos o de bajo estado de animo as! como para personas que siguen dietas especiales por ejemplo la "isodieta", consistente, como ya se ha senalado, en un metodo nutricional basado en el consumo controlado de grasas y protelnas y la reduction del consumo de hidratos de carbono, fruta y verdura, la cual composition, como se ha apuntado anteriormente, esta constituida por una mezcla en polvo conformada esencialmente a base de caseinato de calcio que, ademas, incorpora triptofano.Specifically, what the invention proposes is a protein-based amino acid composition, applicable as a dietary supplement or supplement, especially for vegetarians, athletes or people with transient, depressive or low mood states! as for people who follow special diets for example the "isodiet", consistent, as already noted, in a nutritional method based on the controlled consumption of fats and proteins and the reduction of consumption of carbohydrates, fruit and vegetables, the which composition, as noted above, is constituted by a powder mixture formed essentially based on calcium caseinate, which also incorporates tryptophan.
El caseinato de calcio, como es conocido, es una protelna de alto valor biologico propia de la leche, cuya propiedad esencial es ralentizar el metabolismo de los aminoacidos y con ello prolongar la slntesis de las protelnas.Calcium caseinate, as is known, is a protein of high biological value of milk, whose essential property is to slow down the metabolism of amino acids and thereby prolong the synthesis of proteins.
Por su parte, el triptofano con el que se refuerza la composition propuesta, frente a otros aminoacidos esenciales, permite superar situaciones de carencia de dicho aminoacido, yOn the other hand, the tryptophan with which the proposed composition is reinforced, compared to other essential amino acids, allows to overcome situations of lack of said amino acid, and
55
1010
15fifteen
20twenty
2525
3030
3535
que como es sabido, en determinadas circunstancias de estres, agotamiento o sobreentreno, con mucha frecuencia se convierte en el aminoacido limitante y su escasez puede originar agotamiento, insomnio, bajo estado de animo, falta de energia, etc.that as is known, in certain circumstances of stress, exhaustion or overtraining, very often it becomes the limiting amino acid and its shortage can cause exhaustion, insomnia, low mood, lack of energy, etc.
Tambien es muy conveniente para personas que siguen dietas de estilo vegetariano por ser el aminoacido limitante en muchas de las protemas que contienen los productos vegetales, incluso en una de las mas completas como es la soja.It is also very convenient for people who follow vegetarian-style diets because it is the limiting amino acid in many of the proteins that plant products contain, even in one of the most complete such as soy.
Con la adicion de triptofano a la composicion protemica preconizada se observa una mejora sustancial en el estado de animo y bienestar de deportistas sometidos a entrenamientos severos y, en general, de personas sometidas a estres.With the addition of tryptophan to the recommended protein composition there is a substantial improvement in the mood and well-being of athletes undergoing severe training and, in general, of people under stress.
En concreto, la composicion preconizada contempla una proporcion de triptofano de entre un 1 y un 0,5%, siendo preferentemente los productos que contiene y la proporcion concreta de los mismos la siguiente:Specifically, the recommended composition contemplates a tryptophan ratio of between 1 and 0.5%, preferably the products it contains and the specific proportion thereof as follows:
Caseinato calcico 97,664%Calcium Caseinate 97.664%
Triptofano 0,6%Tryptophan 0.6%
Aroma vainilla 20397 0,833%Aroma vanilla 20397 0.833%
Ciclamato/sacarina 0,833%Cyclamate / saccharin 0.833%
Colorante beta caroteno 0,07%0.07% beta carotene dye
El producto es un preparado en polvo obtenido a partir de un proceso de las materias primas deshidratadas en polvo.The product is a powder preparation obtained from a process of dried powdered raw materials.
Descrita suficientemente la naturaleza de la presente invencion, asi ponerla en practica, no se considera necesario hacer mas extensa que cualquier experto en la materia comprenda su alcance y las ventajas que de ella se derivan, haciendose constar que, dentro de su esencialidad, podra ser llevada a la practica en otras formas de realization que difieran en detalle de la indicada a trtulo de ejemplo, y a las cuales alcanzara igualmente la protection que se recaba siempre que no se altere, cambie o modifique su principio fundamental.Describing sufficiently the nature of the present invention, so putting it into practice, it is not considered necessary to make it more extensive for any expert in the field to understand its scope and the advantages that derive from it, stating that, within its essentiality, it could be carried out in other forms of realization that differ in detail from that indicated by way of example, and to which it will also achieve the protection that is sought as long as it does not alter, change or modify its fundamental principle.
simple de mezcladosimple mixing
como la manera de su explicacion paraas the way of your explanation for
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201301105A ES2536661B1 (en) | 2013-11-27 | 2013-11-27 | Protein composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201301105A ES2536661B1 (en) | 2013-11-27 | 2013-11-27 | Protein composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2536661A1 ES2536661A1 (en) | 2015-05-27 |
| ES2536661B1 true ES2536661B1 (en) | 2016-03-09 |
Family
ID=53184763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201301105A Active ES2536661B1 (en) | 2013-11-27 | 2013-11-27 | Protein composition |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2536661B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2680270B1 (en) * | 2017-03-01 | 2019-06-05 | Espina Roberto Brugos | COMPOSITION FOR PROTEINIC DIETETIC COMPLEMENT |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH658165A5 (en) * | 1984-01-04 | 1986-10-31 | Nestle Sa | FOOD PRODUCT EFFECTIVE IN THE TREATMENT OF LEPROSY. |
| JP4328065B2 (en) * | 2002-07-17 | 2009-09-09 | 日油株式会社 | Enteral nutrition |
| GB2432772B (en) * | 2005-11-30 | 2011-06-01 | Sis | Improvements in and relating to nutritional products |
| FR2981545B1 (en) * | 2011-10-25 | 2014-07-11 | Internat Nutrition Res Company | DIETETIC PRODUCT FOR REDUCING VISCERAL GREASE IN BARIATRIC PREOPERATIVE |
| FR2981544B1 (en) * | 2011-10-25 | 2014-01-31 | Internat Nutrition Res Company | DIETETIC PRODUCT FOR PREVENTING CARDIOMETABOLIC RISK |
-
2013
- 2013-11-27 ES ES201301105A patent/ES2536661B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2536661A1 (en) | 2015-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kopec et al. | Recent advances in the bioaccessibility and bioavailability of carotenoids and effects of other dietary lipophiles | |
| CN103110117B (en) | Compound protein powder and preparation method thereof | |
| MX2009003032A (en) | Phytases, nucleic acids encoding them and methods for making and using them. | |
| BR112013026237A2 (en) | methods of flavor encapsulation and matrix-assisted aqueous food concentration, and products produced from such foods | |
| MX2013006859A (en) | IMPROVED NUTRITIONAL COMPOSITION, ESPECIALLY FOR INFANTS, WITH PARTICULAR FAT PARTICLES. | |
| ES2536661B1 (en) | Protein composition | |
| CN105724917A (en) | Nutritional meal replacement powder containing spirulina components, and production method thereof | |
| RU2014103677A (en) | NEW NANO-GOLD AND METHOD OF MANUFACTURE | |
| ES2551281A1 (en) | Topical cream product for the treatment of skin diseases and obtaining procedure (Machine-translation by Google Translate, not legally binding) | |
| CN103689680A (en) | Food for efficiently supplementing iodine | |
| ES1321611U (en) | Composition from the skin, peel or kernel of the pistachio | |
| ES2680270B1 (en) | COMPOSITION FOR PROTEINIC DIETETIC COMPLEMENT | |
| CN101147551A (en) | Tomato powder product and its preparation method | |
| CN104509918A (en) | Anticancer health function beverage and preparation process thereof | |
| Barakat | Characterization and evaluation of kohlrabi (Brassica oleracea l. Gongylodes) and kohlrabibased ovo-vegetarian diets as new food recipes | |
| PE20110860A1 (en) | PROCEDURE FOR OBTAINING A NATURAL FOOD SUPPLEMENT FOR HUMAN CONSUMPTION | |
| BR102013005726A2 (en) | PROCESS FOR PROPOLIS EXTRACT AND FORMULATION OF ENERGY BEVERAGE SYRUP, PROPOLIS, GUARANÁ AND NATURAL JUICE | |
| Milovanov et al. | Macro-and microscopic systematization of cerebral cortex malformations in children | |
| ES2554204B1 (en) | Crepe product for people and animals and elaboration process | |
| KR20130003083A (en) | A method producing phyto mix food composite new material of black soya powder and raw brown rice | |
| CN105661175A (en) | Sesame paste with walnut kernels | |
| CN105558800A (en) | Noodles with effects of improving intelligence and nourishing brain | |
| ECSP15038053A (en) | NUTRACEUTIC TENTEMPIÉ TYPE FROM LUPINUS MUTABILIS | |
| CN106722896A (en) | A kind of deep-sea fish oligopeptide albumen powder with qi-complementing and spleen-invigorating function | |
| Berendika et al. | Vitamin deficiencies and poultry health |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2536661 Country of ref document: ES Kind code of ref document: B1 Effective date: 20160309 |